Halo Collective Reports 63% Revenue Growth and 345% Cannabis Sales Volume Growth in the Fourth Quarter of 2021
April 1, 2022
Ryan Allway April 1st, 2022 News, Top News TORONTO, April 1, 2022 /CNW/ – Halo Collective Inc. (“Halo” or the “Company”) (NEO: HALO) (OTCQB: HCANF) (Germany: A9KN) today announced its financial and operational results for the fourth quarter (“Q4 2021”) and full year ended December 31, 2021 (“FYE 2021”). www.haloco.com (CNW Group/Halo Collective... Read more
Ryan Allway April 1st, 2022 News, Top News VANCOUVER, BC / ACCESSIRE / April 1, 2022 / 1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis consumer packaged goods company, is pleased to announce its second quarter (“Q2 2022”) financial results for the three and six months... Read more
Ryan Allway April 1st, 2022 News, Top News Old Bethpage, New York, April 01, 2022 (GLOBE NEWSWIRE) — Power REIT (NYSE-AMEX: PW and PW.PRA) (“Power REIT” or the “Trust”), with a focused “Triple Bottom Line” strategy and a commitment to people, planet, and profit, today announced that it is... Read more
Medical Marijuana, Inc. Reports $34.1 Million in Revenue in 2021 Annual Financial and Operational Results Filing
April 1, 2022
Ryan Allway April 1st, 2022 News, Top News SAN DIEGO, CA, April 01, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, today announced its financial... Read more
Bloomios Selected as Exclusive Manufacturer for DRYWORLD’s New Athletic Performance CBD Product Line
March 31, 2022
Ryan Allway March 31st, 2022 News, Top News SANTA BARBARA, Calif., March 31, 2022 /PRNewswire/ — Bloomios, Inc. (OTCQB: BLMS), a leading manufacturer and wholesaler of hemp-derived cannabinoid nutraceuticals and cosmetics, has been selected as the exclusive cannabidiol (CBD) product manufacturer for DRYWORLD (OTC: IBGR), a maker of purpose-driven sports products designed to give athletes... Read more
Delta 9 Announces Closing of Transformative Retail Acquisition, $32 Million Credit Facilities and $10 Million Strategic Financing
March 31, 2022
Ryan Allway March 31st, 2022 News, Top News Closing of Transformative 17 Store retail acquisition securing position as one of Canada’s leading retailers Closing of $32 Million Non-Dilutive Credit Facilities Private Placement from Sundial Growers Inc. of $10 Million in senior secured second-lien convertible debentures WINNIPEG, Manitoba, March 31,... Read more
VIVO Cannabis Announces Fourth Quarter 2021 Results
March 31, 2022
Ryan Allway March 31st, 2022 News, Top News Net revenue for Q4 2021 was $6.9 million; Net revenue for 2021 was $25 million. In February 2021, closed a $7.2 million equity raise to help fund VIVO’s growth In July 2021, the Company elected a new Board of Directors, announced... Read more
Ryan Allway March 31st, 2022 News, Top News PV Live Resin will soon be carried in nearly 400 Michigan dispensaries and available to all Michigan dispensaries Line expansion into higher-margin Live Resin Vapes marks Platinum brand’s first new product in Michigan beyond the wildly popular distillate vape products, with... Read more
Cybin Announces Initiation of Kernel Flow® Feasibility Study Measuring Psychedelic Effects on the Brain
March 31, 2022
Ryan Allway March 31st, 2022 Psychedelics, Top News TORONTO–(BUSINESS WIRE)– Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (Cybin or the Company), a biopharmaceutical company focused on progressing “Psychedelics to TherapeuticsTM”, today announced that the first study visit has been conducted in a Cybin-sponsored feasibility study evaluating Kernel’s quantitative neuroimaging technology, Flow, to measure ketamine’s psychedelic... Read more
Dr AnnaRx Announces Rob Simbowe CBD Muscle and Joint Rubs
CBD March 30, 2022
Ryan Allway March 30th, 2022 News, Top News CAPE TOWN, SA / ACCESSWIRE / March 30, 2022 / WUHAN GENERAL GROUP, INC. (WUHN) (“WGG” or the “Company”), a bioceutical company focused on alternative plant-based cannabinoids and mental health therapeutic research is pleased to share the following update: Dr. AnnaRx™ is pleased... Read more
